Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARD | Q03181 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.35 |
| ▸ | SAT1 | P21673 | 1/20 | 0.35 |
| ▸ | S1PR2 | O95136 | 5/20 | 0.34 |
| ▸ | S1PR4 | O95977 | 5/20 | 0.34 |
| ▸ | S1PR1 | P21453 | 5/20 | 0.34 |
| ▸ | S1PR3 | Q99500 | 5/20 | 0.34 |
| ▸ | CA12 | O43570 | 1/20 | 0.34 |
| ▸ | CA1 | P00915 | 1/20 | 0.34 |
| ▸ | CA2 | P00918 | 1/20 | 0.34 |
| ▸ | CA9 | Q16790 | 1/20 | 0.34 |
| ▸ | S1PR5 | Q9H228 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 2/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL491800 | 0.80 | PPARD (0.62) | PPARDTSHRSAT1S1PR2S1PR4 | |
| SCHEMBL3341956 | 0.79 | PPARD (0.52) | PPARDTSHRSAT1S1PR2S1PR4 | |
| SCHEMBL5918893 | 0.79 | PPARD (0.50) | PPARDTSHRCA12CA1CA2 | |
| SCHEMBL371405 | 0.76 | PPARD (0.48) | PPARDTSHRSAT1S1PR2S1PR4 | |
| SCHEMBL9203519 | 0.75 | PPARD (0.52) | PPARDTSHRSAT1S1PR2S1PR4 | |
| Hydrochloric Acid SCHEMBL5595849 | 0.75 | S1PR2 (0.58) | PPARDTSHRS1PR2S1PR4S1PR1 | |
| SCHEMBL30604707 | 0.75 | PPARD (0.57) | PPARDTSHRSAT1S1PR2S1PR4 | |
| SCHEMBL14768680 | 0.73 | PPARD (0.46) | PPARDTSHRSAT1S1PR2S1PR4 | |
| SCHEMBL15532056 | 0.73 | PPARD (0.65) | PPARDTSHRSAT1S1PR2S1PR4 | |
| SCHEMBL28457642 | 0.73 | PPARD (0.52) | PPARDTSHREPHX1CA12CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3143038-B1 | PEPTIDE-NUCLEIC ACID-MONOMERS AND -OLIGOMERS | UGISENSE AG (DE) | 2018-08-01 | — | — | EP | disclosed |
| US-20170166900-A1 | PEPTIDE NUCLEIC ACID MONOMERS AND OLIGOMERS | UGISENSE AG (DE) | 2017-06-15 | — | — | US | disclosed |
| WO-2015172889-A1 | PEPTIDE NUCLEIC ACID MONOMERS AND OLIGOMERS | UGICHEM GMBH (AT) | 2015-11-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170166900-A1 | PEPTIDE NUCLEIC ACID MONOMERS AND OLIGOMERS | DTYMK, POLM, PNKP | PPARD 3796/4885TSHR 3549/4885EPHX1 4812/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.